Government Support of Meaningful Drug and Device Innovation: Pathways and Challenges

Journal of Law, Medicine and Ethics 51 (S2):7-15 (2023)
  Copy   BIBTEX

Abstract

The US government supports drug innovation. It is therefore crucial that it distinguish between high-value and low-value innovation in purchasing expensive prescription drugs and medical devices and ensure the continued discovery of transformative drugs and that patient and taxpayer funds are not wasted.

Categories

Keywords

Reprint years

DOI

10.1017/jme.2024.21

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 92,261

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

My notes

Similar books and articles

The Government and Pharmaceutical Innovation: Looking Back and Looking Ahead.Bhaven N. Sampat - 2021 - Journal of Law, Medicine and Ethics 49 (1):10-18.
Using Patent Data to Assess the Value of Pharmaceutical Innovation.Aaron S. Kesselheim & Jerry Avorn - 2009 - Journal of Law, Medicine and Ethics 37 (2):176-183.
Formulating an ethics agenda for drug development, regulation, and utilization.L. Lipworth Wendy, H. Kerridge Ian & O. Day Richard - unknown
Coverage for high-cost specialty drugs for rheumatoid arthritis in medicare part D.J. Yazdany, R. A. Dudley, R. Chen, G. A. Lin & C. W. Tseng - unknown
Rethinking Innovation in Drugs: A Pathway to Health for All.Mariana Mazzucato - 2023 - Journal of Law, Medicine and Ethics 51 (S2):16-20.
Development of the logistical support mechanism for the airline’s innovation activity on the market of air transport services.Serhii Smerichevskyi, Igor Kryvovyazyuk, Svitlana Smerichevska, Olena Tsymbalistova, Maryna Kharchenko & Evhen Yudenko - 2020 - International Journal of Management 11 (6):1482-1492.
Index of Names.Xavier Pavie - 2024-02-28 - In Critical Philosophy of Innovation and the Innovator. Hoboken, NJ, USA: Wiley. pp. 165–166.
Targeted Chemotherapy, the Medical Ecosystem, and the Future of American Health Care.Muriel R. Gillick - 2014 - Perspectives in Biology and Medicine 57 (2):268-284.
The Mediating Role of Social Support in the Relationship Between Parenting Styles and Adolescent Drug Abuse Identification.Li Liu, Weijie Meng & Bingyuan Liu - 2022 - Frontiers in Psychology 12.
“Ready for What?”: Timing and Speculation in Alzheimer’s Disease Drug Development.Richard Milne & Natassia F. Brenman - 2022 - Science, Technology, and Human Values 47 (3):597-622.
Vioxx and other pharmaceutical product withdrawals: ethical issues in ensuring the integrity of drug and medical device research, development and commercialization.K. L. Phua & F. I. Achike - 2007 - Clinical Ethics 2 (3):155-162.
What Do We Mean When We Call Someone a Drug Addict?Janet Jones - 2020 - Health Care Analysis 28 (4):391-403.
Action research and innovation in networks, dilemmas and challenges: two cases. [REVIEW]Trond Haga - 2005 - AI and Society 19 (4):362-383.
Where Strategy and Ethics Converge: Pharmaceutical Industry Pricing Policy for Medicare Part D Beneficiaries.Edward R. Balotsky - 2009 - Journal of Business Ethics 84 (S1):75 - 88.
INTRODUCTION: Promoting Drug and Vaccine Innovation and Managing High Prices: Introducing a Special Symposium.Aaron Kesselheim, Ameet Sarpatwari & Benjamin Rome - 2023 - Journal of Law, Medicine and Ethics 51 (S2):5-6.

Analytics

Added to PP
2024-03-05

Downloads
7 (#1,392,075)

6 months
7 (#439,760)

Historical graph of downloads
How can I increase my downloads?

Citations of this work

No citations found.

Add more citations

References found in this work

No references found.

Add more references